Works Cited

1. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545.

2. Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24(4):412-426.

3. Gunderson JG. A BPD Brief: An Introduction to Borderline Personality Disorder: Diagnosis, Origins, Course, and Treatment. Available at http://www.borderlinepersonalitydisorder.com/wp-content/uploads/2011/07/A_BPD_Brief_REV2011.pdf. Last accessed February 14, 2017.

4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.

5. Howe E. Five ethical and clinical challenges psychiatrists may face when treating patients with borderline personality disorder who are or may become suicidal. Innov Clin Neurosci. 2013;10(1):14-19.

6. Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009;166(5):530-539.

7. Gunderson JG, Kolb JE. Discriminating features of borderline patients. Am J Psychiatry. 1978;135(7):792-796.

8. Substance Abuse and Mental Health Services Administration. Report to Congress on Borderline Personality Disorder. Available at https://store.samhsa.gov/shin/content/SMA11-4644/SMA11-4644.pdf. Last accessed February 14, 2017.

9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Publishing; 1980.

10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.

11. Paris J, Gunderson J, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Compr Psychiatry. 2007;48(2):145-154.

12. New AS, Triebwasser J, Charney DS. The case for shifting borderline personality disorder to Axis I. Biol Psychiatry. 2008;64(8): 653-659.

13. Samuel DB, Widiger TA, Pilkonis PA, Miller JD, Lynam DR, Ball SA. Conceptual changes to the definition of borderline personality disorder proposed for DSM-5. J Abnorm Psychol. 2012;121(2):467-476.

14. Oldham JM. The alternative DSM-5 model for personality disorders. World Psychiatry. 2015;14(2):234-236.

15. Biskin RS, Paris J. Diagnosing borderline personality disorder. CMAJ. 2012;184(16):1789-1794.

16. Lenzenweger MF, Loranger AW, Korfine L, Neff C. Detecting personality disorders in a nonclinical population: application of a two-stage procedure for case identification. Arch Gen Psychiatry. 1997;54(4):345-351.

17. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590-596.

18. Gunderson JG, Weinberg I, Choi-Kain L. Borderline personality disorder. FOCUS. 2013;11(2):129-145.

19. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141.

20. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602.

21. Zimmerman M, Chelminski I, Young D. The frequency of personality disorders in psychiatric patients. Psychiatr Clin North Am. 2008;31(3):405-420.

22. Korzekwa MI, Dell PF, Links PS, Thabane L, Webb SP. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatry. 2008;49(4):380-386.

23. Hayashi N, Igarashi M, Imai A, et al. Psychiatric disorders and clinical correlates of suicidal patients admitted to a psychiatric hospital in Tokyo. BMC Psychiatry. 2010;10:109.

24. Gross R, Olfson M, Gameroff M, et al. Borderline personality disorder in primary care. Arch Intern Med. 2002;162(1):53-60.

25. Reid WH. Borderline personality disorder and related traits in forensic psychiatry. J Psychiatr Pract. 2009;15(3):216-220.

26. Black DW, Gunter T, Allen J, et al. Borderline personality disorder in male and female offenders newly committed to prison.Compr Psychiatry. 2007;48(5):400-405.

27. Torgersen S. Epidemiology. In: Wideger T (ed). The Oxford Handbook of Personality Disorders. New York, NY: Oxford University Press; 2012: 186-205.

28. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the national comorbidity survey replication. Biol Psychiatry. 2007;62(6):553-564.

29. Grilo CM, Pagano ME, Skodol AE, et al. Natural course of bulimia nervosa and of eating disorder not otherwise specified: 5-year prospective study of remissions, relapses, and the effects of personality disorder psychopathology. J Clin Psychiatry. 2007;68(5):738-746.

30. Zanarini MC, Frankenburg FR, Ridolfi ME, Jager-Hyman S, Hennen J, Gunderson JG. Reported childhood onset of self-mutilation among borderline patients. J Pers Disord. 2006;20(1):9-15.

31. Loranger AW, Sartorius N, Andreoli A, et al. The International Personality Disorder Examination: The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders.Arch Gen Psychiatry. 1994;51(3):215-224.

32. Johnson JG, Cohen P, Brown J, Smailes EM, Bernstein DP. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry. 1999;56(7):600-606.

33. Carlson EA, Egeland B, Sroufe LA. A prospective investigation of the development of borderline personality symptoms. Dev Psychopathol. 2009;21(4):1311-1334.

34. Chanen AM, Kaess M. Developmental pathways to borderline personality disorder. Curr Psychiatry Rep. 2012;14(1):45-53.

35. Cohen P. Child development and personality disorder. Psychiatr Clin North Am. 2008;31(3):477-493.

36. Fruzzetti AE, Shenk C, Hoffman PD. Family interaction and the development of borderline personality disorder: a transactional model. Dev Psychopathol. 2005;17(4):1007-1030.

37. McLean LM. The relationship between early childhood sexual abuse and the adult diagnoses of borderline personality disorder and complex posttraumatic stress disorder: diagnostic implications. Dissertation Abstracts International. 2001;62(04B):2069.

38. McLean LM, Gallop R. Implications of childhood sexual abuse for adult borderline personality disorder and complex post-traumatic stress disorder. Am J Psychiatry. 2003;160(2):369-371.

39. Chanen AM. Outcomes in women diagnosed with borderline personality disorder in adolescence: early detection and timely intervention are fundamental. J Can Acad Child Adolesc Psychiatry. 2011;20(3):175.

40. Thatcher DL, Cornelius JR, Clark DB. Adolescent alcohol use disorders predict adult borderline personality. Addict Behav. 2005;30(9):1709-1724.

41. Biskin RS, Paris J. Management of borderline personality disorder. CMAJ. 2012;184(17):1897-1902.

42. National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Available at https://www.nhmrc.gov.au/guidelines-publications/mh25. Last accessed February 14, 2017.

43. National Institute for Health and Clinical Excellence. Borderline Personality Disorder: Treatment and Management. Available at https://www.nice.org.uk/guidance/cg78. Last accessed February 14, 2017.

44. Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. The economic burden of personality disorders in mental health care. J Clin Psychiatry. 2008;69(2):259-265.

45. Sansone RA, Sansone LA. Emotional hyper-reactivity in borderline personality disorder. Psychiatry (Edgemont). 2010;7(9):16-20.

46. Sansone RA, Lam C, Wiederman MW. Road rage: relationships with borderline personality and driving citations. Int J Psychiatry Med. 2010;40(1):21-29.

47. Tweed RG, Dutton DG. A comparison of impulsive and instrumental subgroups of batterers. Violence Vict. 1998;13(3):217-230.

48. Trestman RL, Ford J, Zhang W, Wiesbrock V. Current and lifetime psychiatric illness among inmates not identified as acutely mentally ill at intake in Connecticut's jails. J Am Acad Psychiatry Law. 2007;35(4):490-500.

49. Gunderson JG. Borderline personality disorder. N Engl J Med. 2011;364:2037-2042.

50. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295-302.

51. Bender DS, Skodol AE, Pagano ME, et al. Prospective assessment of treatment use by patients with personality disorders. Psychiatr Serv. 2006;57(2):254-257.

52. Pascual JC, Córcoles D, Castaño J, et al. Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service. Psychiatr Serv. 2007;58(9):1199-1204.

53. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004;65(7):903-907.

54. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry. 2004;65(1):28-36.

55. Sansone RA, Sansone LA, Wiederman MW. Borderline personality disorder and health care utilization in a primary care setting. Southern Med J. 1996;89(12):1162-1165.

56. Black DW, Blum N, Letuchy E, Carney Doebbeling C, Forman-Hoffman VL, Doebbeling BN. Borderline personality disorder and traits in veterans: psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity. CNS Spectr. 2006;11(9):680-689.

57. Bell RQ, Chapman M. Child effects in studies using experimental or brief longitudinal approaches to socialization. Dev Psychol. 1986;22:595-603.

58. Ge X, Conger RD, Cadoret RJ, et al. The developmental interface between nature and nurture: a mutual influence model of child antisocial behavior and parent behaviors. Dev Psychol. 1996;32(4):574-589.

59. Kendler KS. Parenting: a genetic-epidemiologic perspective. Am J Psychiatry. 1996;153(1):11-20.

60. Gunderson JG, Lyons-Ruth K. BPD's interpersonal hypersensitivity phenotype: a gene-environment-developmental model. J Pers Disord. 2008;22(1):22-41.

61. Vaughn BE, Lefever GB, Seifer R, Barglow P. Attachment behavior, attachment security, and temperament during infancy. Child Dev. 1989;60(3):728-737.

62. Grossmann K, Grossmann KE, Spangler G, Suess G, Unzner L. Maternal sensitivity and newborns' orientation responses as related to quality of attachment in northern Germany. Monogr Soc Res Child Dev. 1985;50(1-2):233-256.

63. Carlson EA. A prospective longitudinal study of disorganized/disoriented attachment. Child Dev. 1998;69(4):1107-1128.

64. Spangler G, Grossmann KE. Biobehavioral organization in securely and insecurely attached infants. Child Dev. 1993;64(5):1439-1450.

65. van IJzendoorn MH, Schuengel C, Bakermans-Kranenburg MJ. Disorganized attachment in early childhood: meta-analysis of precursors, concomitants, and sequelae. Dev Psychopathol. 1999;11(2):225-249.

66. Holmes J. Disorganized attachment and borderline personality disorder: a clinical perspective. Attach Hum Dev. 2004;6(2):181-190.

67. Spangler G, Fremmer-Bombik E, Grossmann K. Social and individual determinants of infant attachment security and disorganization. Infant Ment Health J. 1996;17(2):127-139.

68. Modell AH. Primitive object relationships and the predisposition to schizophrenia. Int J Psychoanal. 1963;44(3):282-292.

69. Masterson JF. Treatment of the adolescent with borderline syndrome: a problem in separation-individuation. Bull Menninger Clin. 1971;35(1):5-18.

70. Bradley SJ. The relationship of early maternal separation to borderline personality in children and adolescents: a pilot study. Am J Psychiatry. 1979;136(4A):424-426.

71. Gunderson JG, Kerr J, Englund DW. The families of borderlines: a comparative study. Arch Gen Psychiatry. 1980;37(1):27-33.

72. Zweig-Frank H, Paris J. Parents' emotional neglect and overprotection according to the recollections of patients with borderline personality disorder. Am J Psychiatry. 1991;148(5):648-651.

73. Reich DB, Zanarini MC. Developmental aspects of borderline personality disorder. Harv Rev Psychiatry. 2001;9(6):294-301.

74. O'Connor TG, Craft CM. A twin study of attachment in preschool children. Child Dev. 2001;72(5):1501-1511.

75. Finkel D, Wille DE, Matheny AP Jr. Preliminary results from a twin study of infant-caregiver attachment. Behav Genet. 1998;28(1):1-8.

76. Bokhorst CL, Bakermans-Kranenburg MJ, Fearon RM, van IJzendoorn MH, Fonagy P, Schuengel C. The importance of shared environment in mother-infant attachment security: a behavioral genetic study. Child Dev. 2003;74(6):1769-1782.

77. Lyons-Ruth K, Bronfman E, Parsons E. Maternal frightened, frightening, or atypical behavior and disorganized infant attachment patterns. Monogr Soc Res Child Dev. 1999;64(3):67-96.

78. Madigan S, Bakermans-Kranenburg MJ, Van Ijzendoorn MH, Moran G, Pederson DR, Benoit D. Unresolved states of mind, anomalous parental behavior, and disorganized attachment: a review and meta-analysis of a transmission gap. Attach Hum Dev. 2006;8(2):89-111.

79. Lyons-Ruth K, Yellin C, Melnick S, Atwood G. Expanding the concept of unresolved mental states: Hostile/helpless states of mind on the Adult Attachment Interview are associated with disrupted mother-infant communication and infant disorganization. Dev Psychopathol. 2005;17(1):1-23.

80. Hobson RP, Patrick M, Crandell L, García-Pérez R, Lee A. Personal relatedness and attachment in infants of mothers with borderline personality disorder. Dev Psychopathol. 2005;17(2):329-347.

81. White CN, Gunderson JG, Zanarini MC, Hudson JI. Family studies of borderline personality disorder: a review. Harv Rev Psychiatry. 2003;11(1):8-19.

82. Silverman JM, Pinkham L, Horvath TB, et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry. 1991;148(10):1378-1385.

83. Zanarini MC, Frankenburg FR, Yong L, et al. Borderline psychopathology in the first-degree relatives of borderline and Axis II comparison probands. J Pers Dis. 2004;18(5):439-447.

84. van IJzendoorn MH, Goldberg S, Kroonenberg PM, Frenkel OJ. The relative effects of maternal and child problems on the quality of attachment: a meta-analysis of attachment in clinical samples. Child Dev. 1992;63(4):840-858.

85. Wartner UG, Grossmann K, Fremmer-Bombik E, Suess G. Attachment patterns at age six in south Germany: predictability from infancy and implications for preschool behavior. Child Dev. 1994;65(4):1014-1027.

86. Moss E, Parent S, Gosselin C, et al. Attachment and teacher-reported behavior problems during the preschool and early school-age period. Dev Psychopathol. 1996;8(3):511-525.

87. Moss E, Rousseau D, Parent S, St-Laurent D, Saintonge J. Correlates of attachment at school age: maternal reported stress, mother-child interaction, and behavior problems. Child Dev. 1998;69(5):1390-1405.

88. Solomon J, George C, DeJong A. Children classified as controlling at age six: evidence of disorganized representational strategies and aggression at home and at school. Dev Psychopathol. 1995;7(3):447-463.

89. Speltz ML, Greenberg MT, DeKlyen M. Attachment in preschoolers with disruptive behavior: a comparison of clinic-referred and nonproblem children. Dev Psychopathol. 1990;2(1):31-46.

90. Lyons-Ruth K, Melnick S, Patrick M, Hobson RP. A controlled study of hostile-helpless states of mind among borderline and dysthymic women. Attach Hum Dev. 2007;9(1):1-16.

91. Zanarini MC, Williams AA, Lewis RE, et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry. 1997;154(8):1101-1106.

92. Torgersen S, Lygren S, Øien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000;41(6):416-425.

93. Livesley WJ, Jang KL, Jackson DN, Vernon PA. Genetic and environmental contributions to dimensions of personality disorder. Am J Psychiatry. 1993;150(12):1826-1831.

94. Jang KL, Livesley WJ, Vernon PA, Jackson DN. Heritability of personality disorder traits: a twin study. Acta Psychiatr Scand. 1996;94(6):438-444.

95. Distel MA, Willemsen G, Ligthart L, et al. Genetic covariance structure of the four main features of borderline personality disorder. J Pers Disord. 2010;24(4):427-444.

96. Collier DA, Stöber GA, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1(6):453-460.

97. Coccaro EF. Neurotransmitter correlates of impulsive aggression in humans. Ann N Y Acad Sci. 1996;794:82-89.

98. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry. 1992;149(2):221-226.

99. Distel MA, Middeldorp CM, Trull TJ, et al. Life events and borderline personality features: the influence of gene-environment interaction and gene-environment correlation. Psychol Med. 2011;41(4):849-860.

100. Verschoor E, Markus CR. Affective and neuroendocrine stress reactivity to an academic examination: influence of the 5-HTTLPR genotype and trait neuroticism. Biol Psychol. 2011;87(3):439-449.

101. Orr SP, Lasko NB, Macklin ML, et al. Predicting post-trauma stress symptoms from pre-trauma psychophysiologic reactivity, personality traits and measures of psychopathology. Biol Mood Anxiety Disord. 2012;2:8.

102. Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001;50(4):292-298.

103. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry. 2003;54(11):1284-1293.

104. Minzenberg MJ, Fan J, New AS, Tang CY, Siever LJ. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res. 2007;155(3):231-243.

105. Ruocco AC, Medaglia JD, Ayaz H, Chute DL. Abnormal prefrontal cortical response during affective processing in borderline personality disorder. Psychiatry Res. 2010;182(2):117-122.

106. Silbersweig D, Clarkin JF, Goldstein M, et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry. 2007;164(12):1832-1841.

107. Ruocco AC, Amirthavasagam S, Choi-Kain LW, McMain SF. Neural correlates of negative emotionality in borderline personality disorder: an activation-likelihood-estimation meta-analysis. Biol Psychiatry. 2013;73(2):153-160.

108. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(4):651-660.

109. King-Casas B, Sharp C, Lomax-Bream L, Lohrenz T, Fonagy P, Montague PR. The rupture and repair of cooperation in borderline personality disorder. Science. 2008;321(5890):806-810.

110. LeGris J, van Reekum R. The neuropsychological correlates of borderline personality disorder and suicidal behaviour. Can J Psychiatry. 2006;51(3):131-142.

111. Fertuck EA, Lenzenweger MF, Clarkin JF, Hoermann S, Stanley B. Executive neurocognition, memory systems, and borderline personality disorder. Clin Psychol Rev. 2006;26(3):346-375.

112. Zimmerman DJ, Choi-Kain LW. The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review. Harv Rev Psychiatry. 2009;17(3):167-183.

113. Stanley B, Siever LJ. The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry. 2010;167(1):24-39.

114. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC. Oxytocin improves "mind-reading" in humans. Biol Psychiatry. 2007;61(6):731-733.

115. Bartz J, Simeon D, Hamilton H, et al. Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci. 2011;6(5):556-563.

116. Stanley B, Sher L, Wilson S, Ekman R, Huang Y-Y, Mann JJ. Nonsuicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord. 2010;124(1-2):134-140.

117. Pike JL, Smith TL, Hauger RL, et al. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med. 1997;59(4):447-457.

118. Zanarini MC, Yong L, Frankenburg FR, et al. Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J Nerv Ment Dis. 2002;190(6):381-387.

119. Gratz KL. Risk factors for and functions of deliberate self-harm: an empirical and conceptual review. Clinical Psychology Science and Practice. 2003;10(2):192-205.

120. Joyce PR, McKenzie JM, Mulder RT, et al. Genetic, developmental and personality correlates of self-mutilation in depressed patients. Aust N Z J Psychiatry. 2006;40(3):225-229.

121. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci. 1999;3(1):11-21.

122. Fuster JM. Frontal lobe and cognitive development. J Neurocytol. 2002;31(3-5):373-385.

123. Hughes AE, Crowell SE, Uyeji L, Coan JA. A developmental neuroscience of borderline pathology: emotion dysregulation and social baseline theory. J Abnorm Child Psychol. 2012;40(1):21-33.

124. Coan JA. Toward a neuroscience of attachment. In: Cassidy J, Shaver PR (eds). Handbook of Attachment: Theory, Research, and Clinical Implications. 3rd ed. New York, NY: The Guilford Press; 2016: 242-273.

125. Hofer MA. Psychobiological roots of early attachment. Current Directions in Psychological Science. 2006;15(2):84-88.

126. Coan JA. Adult attachment and the brain. Journal of Social and Personal Relationships. 2010;27(2):210-217.

127. Kemeny ME. The psychobiology of stress. Current Directions in Psychological Science. 2003;12(4):124-129.

128. Rolls ET. Emotion elicited by primary reinforcers and following stimulus-reinforcement association learning. In: Coan JA, Allen JJB (eds). The Handbook of Emotion Elicitation and Assessment. New York, NY: Oxford University Press; 2007: 137-157.

129. Eisenberger NI, Taylor SE, Gable SL, Hilmert CJ, Lieberman MD. Neural pathways link social support to attenuated neuroendocrine stress responses. Neuroimage. 2007;35(4):1601-1612.

130. Way BM, Taylor SE, Eisenberger NI. Variation in the mu-opioid receptor gene (OPRM 1) is associated with dispositional and neural sensitivity to social rejection. Proc Natl Acad Sci U S A. 2009;106(35):15079-15084.

131. Cicchetti D, Rogosch FA, Lynch M, Holt KD. Resilience in maltreated children: processes leading to adaptive outcome. Dev Psychopathol. 1993;5(4):629-647.

132. Shields AM, Cicchetti D, Ryan RM. The development of emotional and behavioral self-regulation and social competence among maltreated school-age children. Dev Psychopathol. 1994;6(1):57-75.

133. Asher SR, Coie JD (eds). Peer Rejection in Childhood. New York, NY: Cambridge University Press; 1990.

134. Denham SA, Holt RW. Preschoolers' likability as a cause or consequence of their social behavior. Dev Psychol. 1993;29(2):271-275.

135. Salzinger S, Feldman RS, Hammer M, Rosario M. The effects of physical abuse on children's social relationships. Child Dev. 1993;64(1):169-187.

136. Carpenter RW, Trull TJ. Components of emotion dysregulation in borderline personality disorder: a review. Curr Psychiatry Rep. 2013;15(1):335.

137. Crowell SE, Beauchaine TP, Linehan MM. A biosocial developmental model of borderline personality: elaborating and extending Linehan's theory. Psychol Bull. 2009;135(3):495-510.

138. Domes G, Schulze L, Herpertz SC. Emotion recognition in borderline personality disorder-a review of the literature. J Pers Disord. 2009;23(1):6-19.

139. Wagner AW, Linehan MM. Facial expression recognition ability among women with borderline personality disorder: Implications for emotion regulation? J Pers Disord. 1999;13(4):329-344.

140. Kuo JR, Linehan MM. Disentangling emotion processes in borderline personality disorder: physiological and self-reported assessment of biological vulnerability, baseline intensity, and reactivity to emotionally evocative stimuli. J Abnorm Psychol. 2009;118(3):531-544.

141. Ebner-Priemer UW, Kuo J, Kleindienst N, et al. State affective instability in borderline personality disorder assessed by ambulatory monitoring. Psychol Med. 2007;37(7):961-970.

142. Larsen RJ. The stability of mood variability: a spectral analytic approach to daily mood assessments. J Pers Soc Psychol. 1987;52(6):1195-1204.

143. Trull T, Solhan M, Tragesser SL, et al. Affective instability: measuring a core feature of borderline personality disorder with ecological momentary assessment. J Abnorm Psychol. 2008;117(3):647-661.

144. Gross JJ. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol. 1998;2(3):271-299.

145. Suvak MK, Litz BT, Sloan DM, Zanarini MC, Barrett LF, Hofmann SG. Emotional granularity and borderline personality disorder.J Abnorm Psychol. 2011;120(2):414-426.

146. Coifman KG, Berenson KR, Rafaeli E, Downey G. From negative to positive and back again: polarized affective and relational experience in borderline personality disorder. J Abnorm Psychol. 2012;121(3):668-679.

147. Bornovalova MA, Matusiewicz A, Rojas E. Distress tolerance moderates the relationship between negative affect intensity with borderline personality disorder levels. Compr Psychiatry. 2011;52(6):744-753.

148. Selby EA, Anestis MD, Bender TW, Joiner TE. An exploration of the emotional cascade model in borderline personality disorder.J Abnorm Psychol. 2009;118(2):375-387.

149. Baer RA, Sauer SE. Relationships between depressive rumination, anger rumination, and borderline personality features. Pers Disord Theory Res Treat. 2011;2(2):142-150.

150. Rosenthal ZM, Cheavens JS, Lejuez CW, Lynch TR. Thought suppression mediates the relationship between negative affect and borderline personality disorder symptoms. Behav Res Ther. 2005;43(9):1173-1185.

151. Chapman AL, Dixon-Gordon KL, Walters KN. Experiential avoidance and emotion regulation in borderline personality disorder.J Ration Emot Cogn Behav Ther. 2011;29(1):35-52.

152. Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Personal Individ Differ. 2001;30(4):669-689.

153. Tragesser SL, Robinson RJ. The role of affective instability and UPPS impulsivity in borderline personality disorder features. J Pers Disord. 2009;23(4):370-383.

154. Yen S, Zlotnick C, Costello E. Affect regulation in women with borderline personality disorder traits. J Nerv Ment Dis. 2002;190(10):693-696.

155. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G, Weinberg I, Gunderson JG. The 10-year course of physically self-destructive acts reported by borderline patients and Axis II comparison subjects. Acta Psychiatr Scand. 2008;117(3):177-184.

156. Klonsky ED. The functions of deliberate self-injury: a review of the evidence. Clin Psychol Rev. 2007;27(2):226-239.

157. Bohus M, Limberger M, Ebner U, et al. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior. Psychiatry Res. 2000;95(3):251-260.

158. Ludäscher P, Bohus M, Lieb K, Philipsen A, Jochims A, Schmahl C. Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Res. 2007;149(1-3):291-296.

159. Niedtfeld I, Kirsch P, Schulze L, Herpertz SC, Bohus M, Schmahl C. Functional connectivity of pain-mediated affect regulation in borderline personality disorder. PLoS One. 2012;7(3):e33293.

160. Belsky DW, Caspi A, Arseneault L, et al. Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children. Dev Psychopathol. 2012;24(1):251-265.

161. Johnson AB, Gentile JP, Correll TL. Accurately diagnosing and treating borderline personality disorder: a psychotherapeutic case. Psychiatry (Edgemont). 2010;7(4):21-30.

162. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Borderline Personality Disorder: Guideline Watch. Washington, DC: American Psychiatric Publishing; 2005.

163. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2012;169(5):476-483.

164. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011;68(8):827-837.

165. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord. 2005;19(5):505-523.

166. Gunderson JG, Bender D, Sanislow C, et al. Plausibility and possible determinants of sudden "remissions" in borderline patients. Psychiatry. 2003;66(2):111-119.

167. Yen S, Pagano ME, Shea MT, et al. Recent life events preceding suicide attempts in a personality disorder sample: findings from the collaborative longitudinal personality disorders study. J Consult Clin Psychol. 2005;73(1):99-105.

168. Gunderson JG, Daversa MT, Grilo CM, et al. Predictors of two-year outcome for patients with borderline personality disorder. Am J Psychiatry. 2006;163(5):822-826.

169. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatr Scand. 2010;122(2):103-109.

170. Berenson KR, Downey G, Rafaeli E, Coifman KG, Paquin NL. The rejection-rage contingency in borderline personality disorder.J Abnorm Psychol. 2011;120(3):681-690.

171. Yeomans F. A BPD Teaching Supplement for the Clinical Community. Available at http://remnantsofalife.com/wp-content/uploads/2013/12/TeachingGuide.pdf. Last accessed February 14, 2017.

172. Buteau E, Dawkins K, Hoffman P. In their own words: Improving services and hopefulness for families dealing with BPD. Social Work in Mental Health. 2008;6(1-2):203-214.

173. Horn N, Johnstone L, Brooke S. Some service user perspectives on the diagnosis of borderline personality disorder. J Ment Health. 2007;16(2):255-269.

174. Raven C. Borderline personality disorder: still a diagnosis of exclusion? Ment Health Today. 2009;6:26-31.

175. Paris J. Memories of abuse in borderline patients: true or false? Harv Rev Psychiatry.1995;3(1):10-17.

176. Mead S. Trauma-Informed Peer Support. Available at http://webs.wichita.edu/depttools/depttoolsmemberfiles/ccsr/TIC/Trauma%20informed%20Peer%20Support.pdf. Last accessed February 14, 2017.

177. Grilo CM, Sanislow CA, Skodol AE, et al. Longitudinal diagnostic efficiency of DSM-IV criteria for borderline personality disorder: a 2-year prospective study. Can J Psychiatry. 2007;52(6):357-362.

178. Meyerson DA, Triebwasser J, Passarelli V, Siever LJ. Is Borderline Personality Disorder Underdiagnosed? Paper presented at: American Psychiatric Association Conference; May 2009; San Francisco, CA.

179. Stone M. The Fate of Borderline Patients. New York, NY: The Guilford Press; 1990.

180. Paris J. Why psychiatrists are reluctant to diagnose borderline personality disorder. Psychiatry. 2007;4(1):35-39.

181. Kernberg OF, Yeomans FE. Borderline personality disorder, bipolar disorder, depression, attention deficit/hyperactivity disorder, and narcissistic personality disorder: practical differential diagnosis. Bull Menninger Clin. 2013;77(1):1-22.

182. Paris J. The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category. J Personal Disord. 2007;21(5):457-473.

183. Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry. 2008;165(5):631-638.

184. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757-766.

185. Young JE, Klosko J, Weishaar ME. Schema Therapy: A Practitioner's Guide. New York, NY: The Guildford Press; 2003.

186. Clarkin JF, Yeomans FE, Kernberg OF. Psychotherapy of Borderline Personality: Focusing on Object Relations. Washington, DC: American Psychiatric Press; 2006.

187. Chanen AM, Jovev M, McCutcheon LK, Mcgorry PD. Borderline personality disorder in young people and the prospects for prevention and early intervention. Curr Psychiatry Rev. 2008;4(1):48-57.

188. Wonderlich SA, Rosenfeldt S, Crosby RD, et al. The effects of childhood trauma on daily mood lability and comorbid psychopathology in bulimia nervosa. J Trauma Stress. 2007;20(1):77-87.

189. Miller AL, Muehlenkamp JJ, Jacobson CM. Fact or fiction: diagnosing borderline personality disorder in adolescents. Clin Psychol Rev. 2008;28(6):969-981.

190. Klonsky ED, Olino TM. Identifying clinically distinct subgroups of self-injurers among young adults: a latent class analysis. J Consult Clin Psychol. 2008;76(1):22-27.

191. Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years.J Child Psychol Psychiatry. 2008;49(9):933-941.

192. Pack S, Wakeham S, Beeby R, Fawkes L, Yeandle J, Gordon C. Management of borderline personality disorder. Nurs Times. 2013;109(15):21-23.

193. Agrawal HR, Gunderson J, Holmes BM, Lyons-Ruth K. Attachment studies with borderline patients: a review. Harv Rev Psychiatry. 2004;12(2):94-104.

194. Hines DA. Borderline personality traits and intimate partner aggression: an international multisite, cross-gender analysis. Psychology of Women Quarterly. 2008;32(3):290-302.

195. Dutton DG. Male abusiveness in intimate relationships. Clin Psychol Rev. 1995;15(6):567-581.

196. Westen D, Muderrisoglu S, Fowler C, Shedler J, Koren D. Affect regulation and affective experience: Individual differences, group differences, and measurement using a Q-sort procedure. J Consult Clin Psychol. 1997;65(3):429-439.

197. Mellsop G, Varghese F, Joshua S, Hicks A. The reliability of axis II of DSM-III. Am J Psychiatry. 1982;139(10):1360-1361.

198. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiatry. 2010;71(1):26-31.

199. Zimmerman M, Mattia JI. Differences between clinical and research practices in diagnosing borderline personality disorder. Am J Psychiatry. 1999;156(10):1570-1574.

200. McGrath PJ, Miller JM. Pharmacologic management for treatment-resistant unipolar depression. In: Tasman A, Kay J, Lieberman J, First MB, Riba M (eds). Psychiatry. 4th ed. Chichester: Wiley-Blackwell; 2015.

201. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*d report. Am J Psychiatry. 2006;163(11):1905-1917.

202. Gunderson JG, Morey LC, Stout RL, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry. 2004;65(8):1049-1056.

203. Fiedorowicz JG, Black DW. Borderline, bipolar or both? Frame your diagnosis on the patient history. Curr Psychiatr. 2010;9(1):21-30.

204. Stone MH. Relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006;163(7):1126-1128.

205. Herman J. Trauma and Recovery: The Aftermath of Violence—From Domestic Abuse to Political Terror. New York, NY: Basic Books; 2015.

206. Auchincloss EL, Samberg E (eds). Psychoanalytic Terms and Concepts. New Haven, CT: American Psychoanalytic Association; 2012.

207. Koenigsberg HW, Kernberg OF, Stone MH, Appelbaum AH, Yeomans FE, Diamond D. Borderline Patients: Extending the Limits of Treatability. New York, NY: Basic Books; 2000.

208. Sansone RA, Sansone LA. Gender patterns in borderline personality disorder. Innov Clin Neurosci. 2011;8(5):16-20.

209. Swan SC, Snow DL. A typology of women's use of violence in intimate relationships. Violence Against Women. 2002;8(3):286-319.

210. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15(3):641-685.

211. Kernberg O. The treatment of patients with borderline personality organization. Int J Psychoanal. 1968;49(4):600-619.

212. Kernberg OF. Structural change and its impediments. In: Hartocollis P (ed). Borderline Personality Disorders. 3rd ed. New York, NY: International Universities Press; 1977: 275-306.

213. Maltsberger JT, Buie DH. Countertransference hate in the treatment of suicidal patients. Arch Gen Psychiatry. 1974;30(5):625-633.

214. Gunderson JG. 2014 Lecture for the National Education Alliance for Borderline Personality Disorder. Available at http://www.borderlinepersonalitydisorder.com. Last accessed February 14, 2017.

215. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126(7):983-987.

216. Stiver IP. The meaning of care: reframing treatment models. In: Jordon JV, Kaplan AG, Miller JB, Stiver IP, Surrey JL (eds). Women's Growth in Connection: Writings from the Stone Center. New York, NY: Guilford Press; 1991.

217. Henry KA, Cohen CI. The role of labeling processes in diagnosing borderline personality disorder. Am J Psychiatry. 1983;140(11):1527-1529.

218. Herman JL, Perry JC, van der Kolk BA. Childhood trauma in borderline personality disorder. Am J Psychiatry. 1989;146(4):490-495.

219. Gunderson JG. Borderline Personality Disorder. Washington, DC: American Psychiatric Press; 1984.

220. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry. 1991;148(12):1647-1658.

221. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: The Guilford Press; 1993.

222. Gunderson JG, Links PS. Borderline Personality Disorder: A Clinical Guide. 2nd ed. Washington, DC: American Psychiatric Press, Inc.; 2009.

223. Oldham JM, Gabbard GO, Goin MK, et al. Practice Guideline for the Treatment of Borderline Personality Disorder. Available at http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bpd.pdf. Last accessed February 14, 2017.

224. Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Pers Disord. 2004;18(3):240-247.

225. Larrivée M-P. Borderline personality disorder in adolescents: the He-who-must-not-be-named of psychiatry. Dialogues Clin Neurosci. 2013;15(2):171-179.

226. Soloff PH, Chiappetta L. Prospective predictors of suicidal behavior in borderline personality disorder at 6-year follow-up. Am J Psychiatry. 2012;169(5):484-490.

227. Soloff PH, Chiappetta L. Subtyping borderline personality disorder by suicidal behavior. J Pers Disord. 2012;26(3):468-480.

228. Wedig MM, Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. Predictors of suicide attempts in patients with borderline personality disorder over 16 years of prospective follow-up. Psychol Med. 2012;42(11):2395-2404.

229. Paris J, Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry. 2001;42(6):482-487.

230. Runeson BS, Beskow J, Waern M. The suicidal process in suicides among young people. Acta Psychiatrica Scand. 1996;93(1):35-42.

231. Sansone RA, McLean JS, Wiederman MW. The relationship between medically self-sabotaging behaviors and borderline personality disorder among psychiatric inpatients. Prim Care Companion J Clin Psychiatry. 2008;10(6):448-452.

232. Nelson KJ, Schulz SC. Treatment advances in borderline personality disorder. Psychiatric Annals. 2012;42(2):59-64.

233. Gregory RJ, Jindal S. Factitious disorder on an inpatient psychiatry ward. Am J Orthopsychiatry. 2006;76(1):31-36.

234. Paris JL. Treatment of Borderline Personality Disorder: A Guide to Evidence-Based Practice. New York, NY: The Guilford Press; 2010.

235. Gregory RJ. Managing suicide risk in borderline personality disorder. Psychiatric Times. 2012;5.

236. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45(2):111-119.

237. Skodol AE, Grilo CM, Keyes KM, et al. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry. 2011;168(3):257-264.

238. Yen S, Shea MT, Sanislow CA, et al. Borderline personality disorder criteria associated with prospectively observed suicidal behavior. Am J Psychiatry. 2004;161(7):1296-1298.

239. Gregory RJ. Borderline attributions. Am J Psychother. 2007;61(2):131-147.

240. Cooper J, Kapur N, Webb R, et al. Suicide after deliberate self-harm: a 4-year cohort study. Am J Psychiatry. 2005;162(2):297-303.

241. de Groot ER, Verheul R, Trijsburg RW. An integrative perspective on psychotherapeutic treatments for borderline personality disorder. J Pers Disord. 2008;22(4):332-352.

242. National Registry of Evidence-Based Programs and Practices. Dialectical Behavioral Therapy. Available at http://legacy.nreppadmin.net/ViewIntervention.aspx?id=36. Last accessed February 14, 2017.

243. Sanderson C. Dialectical Behavior Therapy Frequently Asked Questions. Available at http://behavioraltech.org/downloads/dbtFaq_Cons.pdf. Last accessed February 14, 2017.

244. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation: a possible prelude to violence. Science. 2000;289(5479):591-594.

245. National Registry of Evidence-Based Programs and Practices. Systems Training for Emotional Predictability and Problem Solving (STEPPS). Available at http://legacy.nreppadmin.net/ViewIntervention.aspx?id=243. Last accessed February 14, 2017.

246. Thompson AR, Donnison J, Warnock-Parkes E, Turpin G, Turner J, Kerr IB. A multidisciplinary community mental health team staff's experience of a "skills level" training course in cognitive analytic therapy. Int J Ment Health Nurs. 2008;17(2):131-137.

247. National Registry of Evidence-Based Programs and Practices. Dynamic Deconstructive Psychotherapy. Available at http://legacy.nreppadmin.net/ViewIntervention.aspx?id=240. Last accessed February 14, 2017.

248. Zanarini MC. Psychotherapy of borderline personality disorder. Acta Psychiatr Scand. 2009;120(5):373-377.

249. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1355-1364.

250. Kernberg OF, Selzer MA, Koeningsberg HW, Carr AC, Applebaum AH. Psychodynamic Psychotherapy of Borderline Patients. New York, NY: Basic Books; 1989.

251. Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012;(8):CD005652.

252. Neville C. Psychological therapies for borderline personality disorder. Nurs Times. 2014;110(4):25.

253. Neacsiu AD, Lungu A, Harned MS, Rizvi SL, Linehan MM. Impact of dialectical behavior therapy versus community treatment by experts on emotional experience, expression, and acceptance in borderline personality disorder. Behav Res Ther. 2014;53:47-54.

254. Biskin RS. Treatment of borderline personality disorder in youth. J Can Acad Child Adolesc Psychiatry. 2013;22(3):230-234.

255. Bateman AW, Krawitz R. Borderline Personality Disorder: An Evidence-Based Guide for Generalist Mental Health Professionals. Oxford: Oxford University Press; 2013.

256. Chanen AM, Jackson HJ, McCutcheon LK, et al. Early intervention for adolescents with borderline personality disorder: quasi-experimental comparison with treatment as usual. Aust N Z J Psychiatry. 2009;43(5):397-408.

257. Appelbaum AH. Supportive psychotherapy. FOCUS. 2005;3(3):438-460.

258. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry. 2007;164(6):922-928.

259. Hopwood CJ, Swenson C, Bateman A, Yeomans FE, Gunderson JG. Approaches to psychotherapy for borderline personality: demonstrations by four master clinicians. Personal Disord. 2014;5(1):108-116.

260. McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365-1374.

261. Britton PC. Motivational interviewing to address suicidal ideation. In: Arkowitz H, Miller WR, Rollnick S (eds). Motivational Interviewing in the Treatment of Psychological Problems. 2nd ed. New York, NY: Guilford Press; 2017: 193-218.

262. Angstman KB, Rasmussen NH. Personality disorders: review and clinical application in daily practice. Am Fam Physician. 2011;84(11):1253-1260.

263. Searight HR. Efficient counseling techniques for the primary care physician. Prim Care. 2007;34(3):551-570.

264. McMurran M, Cox WM, Coupe S, Whitham D, Hedges L. The addition of a goal-based motivational interview to standardised treatment as usual to reduce dropouts in a service for patients with personality disorder: a feasibility study. Trials. 2010;11:98.

265. Manning S. Dealing with Unrelenting Crisis and Inhibited Grieving in Your Loved One with Borderline Personality Disorder. Available at http://docplayer.net/21816334-Dealing-with-unrelenting-crisis-and-inhibited-grieving-in-your-loved-one-with-borderline-personality-disorder.html. Last accessed February 14, 2017.

266. Ripoll LH. Psychopharmacologic treatment of borderline personality disorder. Dialogues Clin Neurosci. 2013;15(2):213-224.

267. Nelson K, Schulz SC. Pharmacologic treatment of borderline personality disorder. Curr Psychiatry. 2011;10(8):30-40.

268. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196:4-12.

269. Ripoll LH, Triebwasser J, Siever LJ. Evidence-based pharmacotherapy for personality disorders. Int J Neuropsychopharmacol. 2011;14(9):1257-1288.

270. Staebler K, Helbing E, Rosenbach C, Renneberg B. Rejection sensitivity and borderline personality disorder. Clin Psychol Psychother. 2011;18(4):275-283.

271. Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry. 1993;50(5):377-385.

272. Higgins GA, Enderlin M, Haman M, Fletcher PJ. The 5-HT2A receptor antagonist M100,907 attenuates motor and "impulsive-type" behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl). 2003;170(3):309-319.

273. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW. 5HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl). 2004;176(3-4):376-385.

274. Homberg JR. Serotonin and decision-making processes. Neurosci Biobehav Rev. 2012;36(1):218-236.

275. Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev. 2010;(6):CD005653.

276. Zanarini MC, Schulz SC, Detke HC, et al. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2011;72(10):1353-1362.

277. Nickel MK, Loew TH, Pedrosa Gil F. Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Psychopharmacology (Berl). 2007;191(4):1023-1026.

278. Pascual JC, Soler J, Puigdemont D, et al. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry. 2008;69(4):603-608.

279. Frankenburg FR, Zanarini MC. Obesity and obesity-related illnesses in borderline patients. J Personal Disord. 2006;20(1):71-80.

280. Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010;71(1):14-25.

281. Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Personal Disord. 2009;23(2):156-174.

282. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex vs. placebo response in borderline personality disorder. Am J Psychiatry. 2005;162:621-624.

283. Linehan MM, McDavid JD, Brown MZ, Sayrs JH, Gallop RJ. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2008;69(6):999-1005.

284. Soler J, Pascual JC, Campins J, et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry. 2005;162(6):1221-1224.

285. Ziegenhorn AA, Roepke S, Schommer NC, et al. Clonidine improves hyperarousal in borderline personality disorder with or without comorbid post-traumatic stress disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2009;29(2):170-173.

286. Philipsen A, Schmahl C, Lieb K. Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder. Pharmacopsychiatry. 2004;37(5):196-199.

287. Schmahl C, Kleindienst N, Limberger M, et al. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol. 2012;27(1):61-68.

288. Soloff PH, George A, Nathan RS, Schulz PM, Perel JM. Behavioral dyscontrol in borderline patients treated with amitriptyline. Psychopharmacol Bull. 1987;23(1):177-181.

289. Gunderson JG, Frank AF, Ronningstam EF, Wachter S, Lynch VJ, Wolf PJ. Early discontinuance of borderline patients from psychotherapy. J Nerv Ment Dis. 1989;177(1):38-42.

290. Goodman M, Patil U, Triebwasser J, Hoffman P, Weinstein ZA, New A. Parental burden associated with borderline personality disorder in female offspring. J Pers Disord. 2011;25(1):59-74.

291. Hoffman PD, Fruzzetti AE, Buteau E, et al. Family connections: a program for relatives of persons with borderline personality disorder. Fam Process. 2005;44(2):217-225.

292. Gunderson JG, Lyoo IK. Family problems and relationships for adults with borderline personality disorder. Harv Rev Psychiatry. 1997;4(5):272-278.

293. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006;163(5):827-832.

294. Linehan MM, Dimeff LA, Reynolds SK, et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend. 2002;67(1):13-26.

295. Rizvi SL, Dimeff LA, Skutch J, Carroll D, Linehan MM. A pilot study of the DBT coach: an interactive mobile phone application for individuals with borderline personality disorder and substance use disorder. Behav Ther. 2011;42(4):589-600.

296. Kröger C, Schweiger U, Sipos V, et al. Dialectical behaviour therapy and an added cognitive behavioural treatment module for eating disorders in women with borderline personality disorder and anorexia nervosa or bulimia nervosa who failed to respond to previous treatments: an open trial with a 15-month follow-up. J Behav Ther Exp Psychiatry. 2010;41(4):381-388.

Evidence-Based Practice Recommendations Citations

1. National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melbourne: National Health and Medical Research Council; 2012. Summary retrieved from National Guideline Clearinghouse at https://www.guideline.gov/summaries/summary/48553. Last accessed March 28, 2017.

2. Assessment and Management of Risk for Suicide Working Group. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide. Washington, DC: Department of Veterans Affairs, Department of Defense; 2013. Summary retrieved from National Guideline Clearinghouse at https://www.guideline.gov/summaries/summary/47023. Last accessed March 28, 2017.


Copyright © 2017 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.